Cargando…
Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma
BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439755/ https://www.ncbi.nlm.nih.gov/pubmed/37600573 http://dx.doi.org/10.30699/ijp.2023.562466.2977 |
_version_ | 1785093020598665216 |
---|---|
author | Miratashi Yazdi, Seyed Amir Nazar, Elham |
author_facet | Miratashi Yazdi, Seyed Amir Nazar, Elham |
author_sort | Miratashi Yazdi, Seyed Amir |
collection | PubMed |
description | BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with the histopathologic findings of the carcinoma to assess the prognosis. METHODS: This cross-sectional study was conducted on 40 established patients with gastric adenocarcinoma from radical gastrectomy. The patients were classified according to the pathology assessments. Tumoral tissues were assessed by immunohistochemical staining for CD31 expression. Malignant behavior was estimated by histopathological evaluations. RESULTS: CD31 positivity was described in 23 (57.5%) of all evaluated patients. In assessment of CD31 expression and tumor features presented, no significant association between the CD31 expression and patients’ age, sex, tumor site, size, grade and stage, subtypes of carcinoma, perineural invasion, and also lymphovascular invasion was found. (P>0.05). CONCLUSION: Lymphovascular invasion may make valuable additional evidence and may be useful to detect gastric carcinoma patients at high risk for recurrence, who could be candidates for more supplementary therapies. However, in our study, CD31 expression did not show any association with the aggressive histopathologic features of this tumor. |
format | Online Article Text |
id | pubmed-10439755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Iranian Society of Pathology |
record_format | MEDLINE/PubMed |
spelling | pubmed-104397552023-08-20 Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma Miratashi Yazdi, Seyed Amir Nazar, Elham Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with the histopathologic findings of the carcinoma to assess the prognosis. METHODS: This cross-sectional study was conducted on 40 established patients with gastric adenocarcinoma from radical gastrectomy. The patients were classified according to the pathology assessments. Tumoral tissues were assessed by immunohistochemical staining for CD31 expression. Malignant behavior was estimated by histopathological evaluations. RESULTS: CD31 positivity was described in 23 (57.5%) of all evaluated patients. In assessment of CD31 expression and tumor features presented, no significant association between the CD31 expression and patients’ age, sex, tumor site, size, grade and stage, subtypes of carcinoma, perineural invasion, and also lymphovascular invasion was found. (P>0.05). CONCLUSION: Lymphovascular invasion may make valuable additional evidence and may be useful to detect gastric carcinoma patients at high risk for recurrence, who could be candidates for more supplementary therapies. However, in our study, CD31 expression did not show any association with the aggressive histopathologic features of this tumor. Iranian Society of Pathology 2023 2023-06-20 /pmc/articles/PMC10439755/ /pubmed/37600573 http://dx.doi.org/10.30699/ijp.2023.562466.2977 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution- 4.0 International License (https://creativecommons.org/licenses/by/4.0/) which permits Share, copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, even commercially. |
spellingShingle | Original Article Miratashi Yazdi, Seyed Amir Nazar, Elham Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title | Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title_full | Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title_fullStr | Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title_full_unstemmed | Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title_short | Evaluation of Lymphovascular Invasion by CD31 Expression in Gastric Adenocarcinoma |
title_sort | evaluation of lymphovascular invasion by cd31 expression in gastric adenocarcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439755/ https://www.ncbi.nlm.nih.gov/pubmed/37600573 http://dx.doi.org/10.30699/ijp.2023.562466.2977 |
work_keys_str_mv | AT miratashiyazdiseyedamir evaluationoflymphovascularinvasionbycd31expressioningastricadenocarcinoma AT nazarelham evaluationoflymphovascularinvasionbycd31expressioningastricadenocarcinoma |